TLR2-mediated cell stimulation in bacterial vaginosis

Journal of Reproductive Immunology

Volumn 77, Issue 1, 2008, Pages 91-99

  Mares, Debra ^a   Simoes, Jose A ^b   Novak, Richard M ^c   Spear, Gregory T ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Bacterial vaginosis; HIV LTR; Macrophage; Pelvic inflammatory disease; Toll like receptor; Vaginal flora

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIGAND; LIPOPOLYSACCHARIDE; PROTEIN MD 2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL FLORA; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; VAGINITIS;

ADULT; CELL LINE; FEMALE; GENITALIA, FEMALE; HIV LONG TERMINAL REPEAT; HUMANS; INTERLEUKIN-8; NF-KAPPA B; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA; VAGINOSIS, BACTERIAL;

EID: 38149073388     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2007.04.004     Document Type: Article

References (42)

1. Ahmed S.M., Al-Doujaily H., et al. Immunity in the female lower genital tract and the impact of HIV infection. Scand. J. Immunol. 54 1/2 (2001) 225-238
2. Al-Harthi L., Roebuck K.A., et al. Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. J. Acquir. Immune Defic. Syndr. 21 (1999) 194-202
3. Al-Harthi L., Spear G.T., et al. A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the kappaB enhancer. J. Infect. Dis. 178 (1998) 1343-1351
4. Amsel R., Totten P.A., et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74 (1983) 14-22
5. Antonio M.A., Hawes S.E., et al. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J. Infect. Dis. 180 (1999) 1950-1956
6. Asai Y., Ohyama Y., et al. Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2. Infect. Immunol. 69 (2001) 7387-7395
7. Briselden A.M., and Hillier S.L. Longitudinal study of the biotypes of Gardnerella vaginalis. J. Clin. Microbiol. 28 (1990) 2761-2764
8. Buwitt-Beckmann U., Heine H., et al. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J. Biol. Chem. 281 (2006) 9049-9057
9. Darville T., O'Neill J.M., et al. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J. Immunol. 171 (2003) 6187-6197
10. Demba E., Morison L., et al. Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in The Gambia West Africa. BMC Infect. Dis. 5 (2005) 12
11. Deva R., Shankaranarayanan P., et al. Candida albicans induces selectively transcriptional activation of cyclooxygenase-2 in HeLa cells: pivotal roles of Toll-like receptors, p38 mitogen-activated protein kinase, and NF-kappa B. J. Immunol. 171 (2003) 3047-3055
12. Dziarski R., Tapping R.I., et al. Binding of bacterial peptidoglycan to CD14. J. Biol. Chem. 273 (1998) 8680-8690
13. Fisette P.L., Ram S., et al. The Lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-kappaB activation in epithelial cells in a Toll-like receptor 2-dependent manner. J. Biol. Chem. 278 (2003) 46252-46260
14. Fredricks D.N., Fiedler T.L., et al. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 353 (2005) 1899-1911
15. Hajishengallis G., Ratti P., et al. Peptide mapping of bacterial fimbrial epitopes interacting with pattern recognition receptors. J. Biol. Chem. 280 (2005) 38902-38913
16. Hermann C., Spreitzer I., et al. Cytokine induction by purified lipoteichoic acids from various bacterial species-role of LBP, sCD14 CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur. J. Immunol. 32 (2002) 541-551
17. Hillier S.L., Kiviat N.B., et al. Role of bacterial vaginosis-associated microorganisms in endometritis. Am. J. Obstet. Gynecol. 175 (1996) 435-441
18. Hirschfeld M., Ma Y., et al. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165 (2000) 618-622
19. Hirschfeld M., Weis J.J., et al. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immunol. 69 (2001) 1477-1482
20. Kim J.S., Romero R., et al. Distribution of CD14+ and CD68+ macrophages in the placental bed and basal plate of women with preeclampsia and preterm labor. Placenta 28 (2007) 571-576
21. Klebanoff M.A., Hillier S.L., et al. Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation?. Am. J. Obstet. Gynecol. 192 (2005) 470-477
22. Klebanoff S.J., Watts D.H., et al. Lactobacilli and vaginal host defense: activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-kappaB. J. Infect. Dis. 179 (1999) 653-660
23. Kurt-Jones E.A., Mandell L., et al. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100 (2002) 1860-1868
24. Latz E., Visintin A., et al. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277 (2002) 47834-47843
25. Leitich H., Bodner-Adler B., et al. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am. J. Obstet. Gynecol. 189 (2003) 139-147
26. Martin H.L., Richardson B.A., et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180 (1999) 1863-1868
27. Melmed G., Thomas L.S., et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J. Immunol. 170 (2003) 1406-1415
28. Morrison S.G., and Morrison R.P. In situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection. Infect. Immun. 68 (2000) 2870-2879
29. Ness R.B., Kip K.E., et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am. J. Epidemiol. 162 (2005) 585-590
30. Nugent R.P., Krohn M.A., et al. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 29 (1991) 297-301
31. Olinger G.G., Hashemi F.B., et al. Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1. AIDS 13 (1999) 1905-1912
32. Pioli P.A., Weaver L.K., et al. Lipopolysaccharide-induced IL-1 beta production by human uterine macrophages up-regulates uterine epithelial cell expression of human beta-defensin 2. J. Immunol. 176 (2006) 6647-6655
33. Sewankambo N., Gray R.H., et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350 (1997) 546-550
34. Sha B.E., Chen H.Y., et al. Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J. Clin. Microbiol. 43 (2005) 4607-4612
35. Sobel J.D. Bacterial vaginosis. Annu. Rev. Med. 51 (2000) 349-356
36. Spear G.T., al-Harthi L., et al. A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women. AIDS 11 (1997) 1319-1326
37. Sukhikh G.T., Shurshalina A.V., et al. Immunomorphological characteristics of endometrium in women with chronic endometritis. Bull. Exp. Biol. Med. 141 (2006) 104-106
38. Taha T.E., Hoover D.R., et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12 (1998) 1699-1706
39. Verhelst R., Verstraelen H., et al. Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora. BMC Microbiol. 5 (2005) 61
40. Verstraelen H., Verhelst R., et al. Culture-independent analysis of vaginal microflora: the unrecognized association of Atopobium vaginae with bacterial vaginosis. Am. J. Obstet. Gynecol. 191 (2004) 1130-1132
41. Yen S., Shafer M.A., et al. Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military. Obstet. Gynecol. 102 (2003) 927-933
42. Zhang F.X., Kirschning C.J., et al. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 274 (1999) 7611-7614